Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Sun Pharmaceutical Industries Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	524715
ISIN Demat	INE044A01036
Book Value	101.44

NSE Code	SUNPHARMA
Dividend Yield %	0.96
Market Cap	3991773.59

P/E	93.21
EPS	17.85
Face Value	1


	BSE		NSE

26-Jun-2025 13:48

Last Price	1668.00
Net Change	-2.5
% Change	-0.15%
Prev.Close	1670.50
Open	1670.30
High	1678.85
Low	1650.05
Volume	23630

Last Price	1662.80
Net Change	-6.8
% Change	-0.41%
Prev.Close	1669.60
Open	1674.80
High	1678.90
Low	1650.40
Volume	1245007

Value	39414840
Best Buy	1667.40
Best Sell	1668.00
Best Quantity	43
Sell Quantity	100
Today's Range	1678.85
52-Week High	1960.20
52-Week Low	1495.05

Value	2070197639.6
Best Buy	1662.70
Best Sell	1662.80
Best Quantity	119
Sell Quantity	111
Today's Range	1678.90
52-Week High	1960.35
52-Week Low	1495.25

Open Price	1669.10
High Price	1678.90
Low Price	1651.80
Last Price	1669.00
Prev Close	1670.20
Change	-1.20
% Change	-0.07 %

Average Price	1665.56
Underlying Value	1662.80
Number of contracts traded	9001
Turnover in Rs. Lakhs	52471
Open Interest	4759300.00
Change in O I	853650.00
% Change in O I	21.86 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	43
Price	1667.40

Quantity	100
Price	1668.00

Best Bid

Best Offer

Quantity	119
Price	1662.70

Quantity	111
Price	1662.80

Best Bid

Best Offer

Quantity	350
Price	1668.5

Quantity	700
Price	1669

Holding Details

Latest Corporate Events

Bonus

1 : 1

29-Jul-13

Book Closure

25-Aug-21

31-Aug-21

Dividend

550 %

07-Jul-25

Company News

25-06-2025

Sun Pharmaceutical Indus...

25-06-2025

Sun Pharma’s partner with...

25-06-2025

Sun Pharma gains on the B...

14-06-2025

USFDA conducts GMP inspec...

26-05-2025

Sun Pharmaceutical Indust...

23-05-2025

Sun Pharmaceutical Indust...

24-04-2025

Sun Pharmaceutical Indust...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.